SPRITZE

European patent · EP3470058 · In force

Register entry

Publication number
EP3470058
Application number
EP18202752
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 25, 2013
Published
Apr 17, 2019
Granted
Aug 26, 2026
Protection ends at the latest
Jan 24, 2033
Next annual fee due
Jan 31, 2027
IPC classes
A61K 9/00 (2006.01)
A61M 5/28 (2006.01)
A61M 5/31 (2006.01)
A61M 5/315 (2006.01)
Priority
EP 12174860 03.07.2012
EP 12189649 23.10.2012
DE 202012011016 U 16.11.2012
AU 2012101677 16.11.2012
AU 2012101678 16.11.2012
DE 202012011260 U 23.11.2012
DE 202012011259 U 23.11.2012
EP 12195360 03.12.2012
DE 202013000688 U 23.01.2013
AU 2013100071 23.01.2013
AU 2013100070 23.01.2013
Divided from
EP13701276
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 28, 2026

    Agent entered

    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 28.08.2026

  2. Aug 26, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 26.08.2026

Parties

Holder

Novartis AG

Lichtstrasse 35, 4056 Basel

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventor

SIGG, Juergen

4002 Basel

ROYER, Christophe

4002 Basel

BRYANT, Andrew Mark

4002 Basel

BUETTGEN, Heinrich Martin

4002 Basel

PICCI, Marie

4002 Basel

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.